Yangmin Qiu

Years Active: 2020-2021
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Yunqian Qiao, Yangmin Qiu, Jie Ding, Nana Luo, Hao Wang, Xiaomin Ling, Jiya Sun, Zhihai Wu, Yisen Wang, Yanpeng Liu, Feifei Guo, Ta Sun, Wanwan Shen, Min Zhang, Dongdong Wu, Bingliang Chen, Wei Xu, Xuan Wang
Cancer immune therapy with PD-1-dependent CD137 co-stimulation provides localized tumour killing without systemic toxicity. Nature communications 12 (1) (2021)
Binyan Lin, Yongxu Li, Tiepeng Wang, Yangmin Qiu, Zhenzhong Chen, Kai Zhao, Na Lu
CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK. Oncogene 39 (37) (2020)

Yangmin Qiu.css-eqlu8i{font-size:small;padding-left:4px;}